About Star Lake Bioscience
Star Lake Bioscience is a company based in Zhaoqing (China) founded in 1964. The company has 9,290 employees. Star Lake Bioscience has completed 1 acquisition, including Ningxia Eppen Biotech.
- Headquarter Zhaoqing, China
- Employees 9,290
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website starlake.com.cn
- Social LinkedIn
- Legal Name Star Lake Bioscience Co., Inc. Class A
- Annual Revenue$2.27 B (USD)-8.29as on Dec 31, 2025
- Net Profit$139.82 M (USD)3.79as on Dec 31, 2025
- EBITDA$288.53 M (USD)-16.36as on Dec 31, 2025
- Employee Count9,290
- Investments & Acquisitions
IPO & Listings of Star Lake Bioscience
Star Lake Bioscience is a publicly listed company on the SSE with ticker symbol 600866 in China, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Aug 1994
- Listed onSSE: 600866
- Listed entityStar Lake Bioscience Co., Inc. Class A
- Exchange sectorConsumer non-durables
- ISINCNE000000H46
- Share price4.40 CNY (+3.53% on the day) · 2026-10-09
- Market capitalisation7,310,479,846.00 CNY
- Price to earnings34.3
- EPS (diluted, trailing year)0.13 CNY
- Dividend yield8.64%
- Volume (last session)35,131,646
Financials of Star Lake Bioscience
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 15.87B CNY | 978.9M CNY | 2.02B CNY |
| 2024 | 17.31B CNY | 943.1M CNY | 2.42B CNY |
| 2023 | 17.36B CNY | 678.0M CNY | 2.02B CNY |
| 2022 | 17.45B CNY | 608.3M CNY | 2.71B CNY |
| 2021 | 4.06B CNY | 152.1M CNY | 606.7M CNY |
Detailed financial statements for Star Lake Bioscience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Star Lake Bioscience
Star Lake Bioscience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Ningxia Eppen Biotech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of animal, plant and human nutrition | eppen.com.cn | Yinchuan, China | 1999 | Jun 2022 | •••• |
Complete acquisition details for Star Lake Bioscience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Star Lake Bioscience
3 dated milestones of Star Lake Bioscience across 58 years, from founding to its latest funding, stage changes and deals.
- Founded Star Lake Bioscience is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Ningxia Eppen Biotech.
Web traffic of Star Lake Bioscience
Websites that share an audience with Star Lake Bioscience (starlake.com.cn).
Websites whose visitors overlap most with Star Lake Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
omnichemusa.com | omnichemusa.com | 100% | – | – | – |
ndc-india.com | ndc-india.com | 100% | – | – | – |
| herochem.com | 100% | – | – | View details | |
| chempacific.com | 100% | – | – | View details | |
| porton.cn | 100% | 31.8K | #899,543 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Star Lake Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Star Lake Bioscience
Complete news archive for Star Lake Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Star Lake Bioscience
10 companies that operate in the same segment as Star Lake Bioscience (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Star Lake Bioscience
Star Lake Bioscience was founded in 1964.
Star Lake Bioscience is headquartered in Zhaoqing, China. It is registered at Zhaoqing, Guangdong, China.
Star Lake Bioscience has 9,290 employees.
Annual revenue of Star Lake Bioscience is $2.27B as on Dec 31, 2025.
Star Lake Bioscience was founded in 1964 and is headquartered in Zhaoqing, China. Operations focus on the production and distribution of pharmaceutical intermediates, as well as additives for food and animal feed, serving markets in China and abroad. Key products include guanosine for pharmaceutical and food applications, and L-threonine for use in pig and poultry feed premixtures. The company operates within the bioscience sector.
Yes, Star Lake Bioscience is publicly traded on SSE under the ticker symbol 600866.
Star Lake Bioscience has made 1 acquisition, including Ningxia Eppen Biotech.